Evidence map›Paper›PMID 24955333›Full record

ArticleJournal of preventive cardiology2013

Impact of omega-6 fatty acids on cardiovascular outcomes: A review.

Shweta Khandelwal, Laura Kelly, Richa Malik, Dorairaj Prabhakaran, Srinath Reddy

Open access · greenAbstract read
In one paragraph

Article in Journal of preventive cardiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. The Effects ofVeterinary medicine international · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The Relationship Between Nutrition and Atherosclerosis.Frontiers in bioengineering and biotechnology · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Effect of PUFA-rich plant oil on risk factors of STZ-induced diabetes in Wistar rats.Redox report : communications in free radical research · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Shweta KhandelwalCentre for Chronic Disease Control, New Delhi, India ; Public Health Foundation of India, New Delhi, India.
Laura KellyRollins School of Public Health, Emory University, Atlanta.
Richa MalikPublic Health Foundation of India, New Delhi, India.
Dorairaj PrabhakaranCentre for Chronic Disease Control, New Delhi, India.
Srinath ReddyPublic Health Foundation of India, New Delhi, India.
Public Health Foundation of India · INCentre for Chronic Disease Control · INEmory University · US

Funding

GRADUATE TRAINING IN DEMOGRAPHYT32HD007242 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI MICHEL GUILLOT · 1985 to 2026
$6.6M
Interdisciplinary research training: NCD epidemiology and prevention in IndiaD43HD065249 · NICHD · CENTRE FOR CHRONIC DISEASE CONTROL · PI NARAYAN, KABAYAM M VENKAT, TANDON, NIKHIL · 2009 to 2013
$1.2M
NICHD NIH HHS D43 HD065249NICHD NIH HHS T32 HD007242
6 · The paper itself

Abstract

Poly unsaturated fatty acids (PUFAs) have usually been associated with beneficial health effects on early life and later life disease such as cardiovascular diseases (CVD). Emerging evidence, however, suggests that PUFA species (n-3, n-6) have differential health effects. N-6 PUFAs, in particular, have sparked a scientific debate regarding their role in human physiological processes. Current dietary recommendations for n-6 fatty acids have been based on animal studies, insufficient epidemiological evidence and mixed PUFA interventions, therefore, require reconsideration. This review has analyzed human epidemiological and interventional studies, published in the last five years, focusing on n-6 fatty acids' impact on CVD outcomes (CVD events, blood lipids, blood pressure, inflammation, oxidative stress/atherosclerosis). The evidence is mixed, with differential effects within the n-6 fatty acid series. These outcomes are also dependent on ethnicity and background health status. Further, data from developing countries are sparse, thus, well designed intervention trials and population based studies in developing country settings on specific n-6 fatty acid intake and health effects are desired.

Indexed as

Cardiovascular disordersChronic diseasesOmega-6 fatty acidsPolyunsaturated fatty acidsReviewRisk factors

Identifiers

PMID24955333
PMCPMC4062196
OpenAlexW1962087838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.